Markers as the CD44 [37] or cyclin D1 [38] have been proposed as differentially expressed genes between malignant and benign papillary lesions, but there is no correlation with malignant recurrence of intraductal papillomas. This evidence concerns the gene CD44 and intraductal papilloma.